Last update:

Immunology news

Medications

Newly discovered compounds help cells fight a wide range of viruses

Researchers at MIT and other institutions have identified compounds that can fight off viral infection by activating a defense pathway inside host cells. These compounds, they believe, could be used as antiviral drugs that ...

Oncology & Cancer

Researchers develop novel antibody-RNA therapy for resistant cancers

A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors significantly improved survival and reduced tumor sizes in animal models, according to a study reported ...

Diseases, Conditions, Syndromes

How lung repair mechanisms can help fight against tuberculosis

New research has found that delivering a stronger form of the tuberculosis vaccine directly to the lungs can help generate protective immune cells to help fight the disease. The research is published in the journal Mucosal ...

Oncology & Cancer

A new framework for understanding and tackling CAR T toxicities

Immunotherapy using CAR T cells is finding ever more applications. In addition to their use in the treatment of blood and lymphatic cancers, CAR T cells are now also being investigated for solid tumors and various autoimmune ...

Diseases, Conditions, Syndromes

Measles isn't just dangerous, it may erase your immune system

Blindness, pneumonia, severe diarrhea and even death—measles virus infections, especially in children, can have devastating consequences. Fortunately, we have a safe and effective defense. Measles vaccines are estimated ...

Immunology

Penicillin allergy testing needed to fight antibiotic resistance

Penicillins are first-choice antibiotics for many common infections, but more than one in 15 UK adults have a penicillin allergy label on their medical records. In the event of an infection, they will be prescribed alternative ...

Immunology

Cancer drug shows promise as treatment for blindness

Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), shows potential as a new treatment approach for two leading causes of blindness ...

Immunology

New route into cells could make gene therapies safer

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular ...

Oncology & Cancer

Controlled physical barrier created to boost cancer immunotherapy

A study led by Prof. Liang Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of Sciences (CAS) reported a biomimetic physical barrier (BPB) that temporarily blocks T cell-tumor ...

Immunology

Immunotherapy resistance linked to cytoplasmic WEE1 protein

Immune checkpoints are regulatory proteins that prevent the immune system from attacking healthy tissues. Some cancer cells exploit these checkpoints to avoid immune detection. Immune checkpoint blockade (ICB)—a therapy ...

Oncology & Cancer

Plant compound slows cervical cancer growth in preclinical model

Cervical cancer is one of the most common gynecologic cancers worldwide and continues to be a leading cause of cancer-related death in women. While early detection through screening has improved outcomes, treatment options ...

Immunology

Isocyanic acid identified as anti-inflammatory metabolite

In a recent study published in Science Advances, researchers led by Prof. Li Xinjian from the Institute of Biophysics of the Chinese Academy of Sciences have uncovered a novel immunoregulatory function of isocyanic acid (ICA), ...

Diseases, Conditions, Syndromes

Naturally occurring molecule shows promise for lupus treatment

Systemic lupus erythematosus, or lupus, is a complex autoimmune disease in which the immune system mistakenly attacks healthy tissue, often affecting the skin, joints, kidneys and nervous system. Lupus symptoms include inflammation, ...